EN | SE Contact us

Share price

BioInvent International AB is listed on NASDAQ OMX Stockholm (BINV)


+/- +/- Open Bid Ask High Low Volume Turnover Updated


Shareprice information


Subscription service



Webcast Link
Interview with Björn Frendéus, acting CEO, Dagens Industri, Lund, 24 July, 2018 (Swedish) Click here
Redeye Pre-ASCO Seminar, Stockholm, Sweden, May 28, 2018 Click here
Interview with Michael Oredsson, CEO och Björn Frendéus, CSO, Redeye, Lund, December 18, 2017 (Swedish) Click here
Aktiespararna, Stockholm, Sweden, October 17, 2017 (Swedish) Click here
Aktiespararna, Malmö, Sweden, September 27, 2017 (Swedish) Click here
ProHearings, Stockholm, Sweden, September 8, 2017 (Swedish) Click here
Aktiespararna, Lund, Sweden, January 31, 2017 (Swedish) Click here
Aktiespararna, Stockholm, Sweden, November 28, 2016 (Swedish) Click here
Finwire TV: BioInvent, March 29, 2016 (Swedish) Click here
Aktiespararna, Jönköping, Sweden, March 15, 2016 (Swedish) Click here
Ladenburg Thalmann Healthcare Conference, New York, USA, 29 September, 2015 Click here
Small Business Day, Stockholm, Sweden, 8 June, 2015 (Swedish) Click here
Interview with Bioinvent's CEO Michael Oredsson, Redeye, Stockholm, Sweden, April 10, 2015 (Swedish) Click here
Investor Forum Redeye, Stockholm, Sweden, November 11, 2014 (Swedish) Click here


Title Download
Corporate presentation, October 17,2018 . Download pdf (2.58 Mb)
CEO's report for 2017, Lund, Sverige, april 24, 2018. Download pdf (2.77 Mb)
Redeye Stockholm Sweden September 21 2017 (Swedish) Download pdf (5.07 Mb)
CEO's report for 2016, Lund, Sverige, maj 17, 2017 Download pdf (2.54 Mb)
Aktiespararna, Lund, Sverige, januari 31, 2017 Download pdf (0.83 Mb)
Aktiespararna, Stockholm, Sverige, november 28, 2016 Download pdf (2.67 Mb)
Live Chat Session Småbolagsjakten, Facebook, november 14, 2016. Download pdf (0.55 Mb)
Capital Market Day, Stockholm, Sverige, juni 13, 2016 Download pdf (12.47 Mb)
Aktiespararna, Jönköping, Sverige, mars 15, 2016 Download pdf (0.96 Mb)
Ladenburg Thalmann Healthcare Conference, New York, USA, september 29, 2015 Download pdf (0.9 Mb)
Capital Market Day, Stockholm, Sverige, mars 23, 2015 Download pdf (4.17 Mb)
Investor Forum Redeye, Stockholm, Sverige, november 11, 2014 Download pdf (0.38 Mb)
Öresund Investment Day, Lund, Sverige, september 22, 2014 Download pdf (0.4 Mb)
Small Business Day, Stockholm, Sverige, juni 9, 2014 Download pdf (1.04 Mb)
Pareto Öhman Health Care Seminar, Stockholm, Sverige, augusti 29, 2013 Download pdf (1.17 Mb)

Investor information

Please find information in this section on our financial calendar, analysts who follow BioInvent and out largest owners.

Choose from the links to access the information.


Financial calendar





Corporate governance

BioInvent applies the Swedish Code of Corporate Governance ("the Code"). In addition to the Code, BioInvent also complies with applicable rules in the Swedish Companies Act, rules and recommendations ensuring from the Company's listing on NASDAQ OMX Stockholm, and good practices on the stock market.

Investor contact

Martin Welschof, CEO Tel. +46 (0)46-286 85 50

E-mail: martin.welschof@bioinvent.com

Subscription service

Email Subscription